170 related articles for article (PubMed ID: 31562226)
1. Comparison of 3 Interpretation Criteria for
Toriihara A; Nobashi T; Baratto L; Duan H; Moradi F; Park S; Hatami N; Aparici CM; Davidzon G; Iagaru A
J Nucl Med; 2020 Apr; 61(4):533-539. PubMed ID: 31562226
[TBL] [Abstract][Full Text] [Related]
2. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
[TBL] [Abstract][Full Text] [Related]
3. Detection Threshold and Reproducibility of
Lückerath K; Stuparu AD; Wei L; Kim W; Radu CG; Mona CE; Calais J; Rettig M; Reiter RE; Czernin J; Slavik R; Herrmann K; Eiber M; Fendler WP
J Nucl Med; 2018 Sep; 59(9):1392-1397. PubMed ID: 29602819
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer.
Tulsyan S; Das CJ; Tripathi M; Seth A; Kumar R; Bal C
Nucl Med Commun; 2017 Dec; 38(12):1094-1102. PubMed ID: 28957842
[TBL] [Abstract][Full Text] [Related]
5. Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions.
Fanti S; Minozzi S; Morigi JJ; Giesel F; Ceci F; Uprimny C; Hofman MS; Eiber M; Schwarzenbock S; Castellucci P; Bellisario C; Chauvie S; Bergesio F; Emmett L; Haberkorn U; Virgolini I; Schwaiger M; Hicks RJ; Krause BJ; Chiti A
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1622-1635. PubMed ID: 28536833
[TBL] [Abstract][Full Text] [Related]
6. Whole-Body Integrated [
Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
[TBL] [Abstract][Full Text] [Related]
7. Clinical performance of
Kranzbühler B; Nagel H; Becker AS; Müller J; Huellner M; Stolzmann P; Muehlematter U; Guckenberger M; Kaufmann PA; Eberli D; Burger IA
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):20-30. PubMed ID: 29032394
[TBL] [Abstract][Full Text] [Related]
8. PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer.
Giesel FL; Fiedler H; Stefanova M; Sterzing F; Rius M; Kopka K; Moltz JH; Afshar-Oromieh A; Choyke PL; Haberkorn U; Kratochwil C
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1794-800. PubMed ID: 26162799
[TBL] [Abstract][Full Text] [Related]
9. Integrated
Lütje S; Cohnen J; Gomez B; Grüneisen J; Sawicki L; Rübben H; Bockisch A; Umutlu L; Pöppel TD; Wetter A
Nuklearmedizin; 2017 Jun; 56(3):73-81. PubMed ID: 28401244
[TBL] [Abstract][Full Text] [Related]
10.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
11. Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer.
Minamimoto R; Hancock S; Schneider B; Chin FT; Jamali M; Loening A; Vasanawala S; Gambhir SS; Iagaru A
J Nucl Med; 2016 Apr; 57(4):557-62. PubMed ID: 26659347
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Intra-individual comparison of (68)Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer.
Giesel FL; Sterzing F; Schlemmer HP; Holland-Letz T; Mier W; Rius M; Afshar-Oromieh A; Kopka K; Debus J; Haberkorn U; Kratochwil C
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1400-6. PubMed ID: 26971788
[TBL] [Abstract][Full Text] [Related]
14. A VISION Substudy of Reader Agreement on
Kuo PH; Yoo DC; Avery R; Seltzer M; Calais J; Nagarajah J; Weber WA; Fendler WP; Hofman MS; Krause BJ; Brackman M; Kpamegan E; Ghebremariam S; Benson T; Catafau AM; Kendi AT
J Nucl Med; 2023 Aug; 64(8):1259-1265. PubMed ID: 37230533
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy of Multiparametric MRI versus
Muehlematter UJ; Burger IA; Becker AS; Schawkat K; Hötker AM; Reiner CS; Müller J; Rupp NJ; Rüschoff JH; Eberli D; Donati OF
Radiology; 2019 Nov; 293(2):350-358. PubMed ID: 31502937
[TBL] [Abstract][Full Text] [Related]
16. Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.
Demirci E; Akyel R; Caner B; Alan-Selçuk N; Güven-Meşe Ş; Ocak M; Kabasakal L
Nucl Med Commun; 2020 Aug; 41(8):759-767. PubMed ID: 32453205
[TBL] [Abstract][Full Text] [Related]
17. A Pilot Study of
Duan H; Ghanouni P; Daniel B; Rosenberg J; Davidzon GA; Aparici CM; Kunder C; Sonn GA; Iagaru A
J Nucl Med; 2023 Apr; 64(4):592-597. PubMed ID: 36328488
[TBL] [Abstract][Full Text] [Related]
18. A Pilot Study of
Duan H; Ghanouni P; Daniel B; Rosenberg J; Thong A; Kunder C; Aparici CM; Davidzon GA; Moradi F; Sonn GA; Iagaru A
J Nucl Med; 2023 May; 64(5):744-750. PubMed ID: 36396456
[TBL] [Abstract][Full Text] [Related]
19. Interobserver agreement of [
Derwael C; Lavergne O; Lovinfosse P; Nechifor V; Salvé M; Waltregny D; Hustinx R; Withofs N
EJNMMI Res; 2020 Feb; 10(1):15. PubMed ID: 32112230
[TBL] [Abstract][Full Text] [Related]
20. Comparison between
Tseng JR; Yu KJ; Liu FY; Yang LY; Hong JH; Yen TC; Pang ST; Wang LJ
J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):688-696. PubMed ID: 32739147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]